INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$1.12 USD
-0.04 (-3.45%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $1.11 -0.01 (-0.89%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Price, Consensus and EPS Surprise
INBS 1.12 -0.04(-3.45%)
Will INBS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INBS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for INBS
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
Intelligent Bio Solutions partners with CenExel
Intelligent Bio Solutions Announces Key CenExel Partnership
Intelligent Bio announces QabasTech as exclusive distributor in Saudi Arabia
Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia